May 2007
Volume 48, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2007
The Influence of Heparin, Heparan Sulfate, and C-reactive Protein on the Cofactor Activity of Complement Factor H (402HH and 402YY)
Author Affiliations & Notes
  • U. L. Kelly
    Duke University Eye Center, Durham, North Carolina
    Ophthalmology,
  • L. Yu
    Duke University Eye Center, Durham, North Carolina
    Ophthalmology,
  • V. Y. Arshavsky
    Duke University Eye Center, Durham, North Carolina
    Ophthalmology,
  • M. A. Hauser
    Medicine and Center for Human Genetics,
    Duke University Medical Center, Durham, North Carolina
  • H. Jiang
    Pediatrics,
    Duke University Medical Center, Durham, North Carolina
  • M. Frank
    Pediatrics,
    Duke University Medical Center, Durham, North Carolina
  • C. Bowes Rickman
    Duke University Eye Center, Durham, North Carolina
    Ophthalmology and Cell Biology,
  • Footnotes
    Commercial Relationships U.L. Kelly, None; L. Yu, None; V.Y. Arshavsky, None; M.A. Hauser, None; H. Jiang, None; M. Frank, None; C. Bowes Rickman, None.
  • Footnotes
    Support FFB Individual Grant, Steinbach Fund, NEI Core EY005722, RPB Core, EY012118
Investigative Ophthalmology & Visual Science May 2007, Vol.48, 14. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      U. L. Kelly, L. Yu, V. Y. Arshavsky, M. A. Hauser, H. Jiang, M. Frank, C. Bowes Rickman; The Influence of Heparin, Heparan Sulfate, and C-reactive Protein on the Cofactor Activity of Complement Factor H (402HH and 402YY). Invest. Ophthalmol. Vis. Sci. 2007;48(13):14.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose:: A cell-based functional assay that measures the cofactor activity of factor H on factor I mediated iC3b formation was used to study the modulation of this activity by heparin, heparan sulfate (HS) and C-reactive protein (CRP). Purified samples of factor H from individuals homozygous for either the major genetic risk factor for age-related macular degeneration (AMD) form (402HH) or normal (402YY) were used to determine whether this amino acid substitution influences the kinetics of the reaction.

Methods:: A functional factor H-cofactor activity assay, which quantitates the inactivation of cell-bound radiolabeled C3b by human factor H, and factor I was used to study iC3b formation as a function of time. iC3b formation was detected by low dose trypsin to release C3c. Purified, isoform specific, factor H was incubated with factor I and cell-bound C3b. In parallel studies, cold, cell-bound, C3b was used with radiolabeled anti-factor H to track the binding of factor H to the cells under similar conditions. Experiments were performed in the presence or absence of heparin, heparan sulfate, or CRP and the results confirmed by immunoblot analysis of factor H in the cell lysate after specific times of incubation.

Results:: Under normal conditions factor H rapidly binds to the cells. In the presence of HS, factor H binding was enhanced after 1 minute of incubation at 37 degrees. Heparin decreased binding of factor H to the cells and CRP had no effect. Results measuring iC3b formation parallel these findings: heparan sulfate increased iC3b formation, heparin decreased it and CRP had no effect. Results of these experiments were identical with either factor H isoform (402HH or the 402YY).

Conclusions:: Heparan sulfate increased factor H mediated proteolytic cleavage of C3b by factor I as evidenced by increased formation of iC3b. This may be due to HS increasing binding of factor H to C3b-coated cells. Heparin decreased the binding of factor H to the C3b-coated cells with concomitant decreased formation of iC3b. CRP had no effect under the conditions used. Understanding the mechanism of action of factor H and the influence of various biological molecules associated with AMD pathology on this reaction may give us an insight into the role of factor H in the pathogenesis of AMD.

Keywords: age-related macular degeneration • immunomodulation/immunoregulation • proteoglycans/glycosaminoglycans 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×